User:Mr. Ibrahem/Bexarotene

Bexarotene, sold under the brand Targretin among others, is a medication use to treat cutaneous T cell lymphoma (CTCL). It is used by mouth for advanced disease and applied to the skin for early disease. It is used when other treatments have failed.

Common side effects by mouth include high cholesterol, headaches, low thyroid, low white blood cells, rash, nausea, infection, dry skin, and peripheral swelling. Common side effects when applied to the skin include rash and itchiness. Other side effects may include liver problems, pancreatitis, and sunburns. Use in pregnancy may harm the baby. It is a retinoid. How it works is unclear.

Bexarotene was approved in the United States in 1999 and Europe in 2001. It is available as a generic medication. In the United Kingdom 100 pills of 75 mg costs the NHS about £940 as of 2021. This amount in the United States is about 2,050 USD.